𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Idiotype-anti-idiotype interactions and the control of the anti-β(2→6) polyfructosan response in the mouse: specificity and idiotypy of anti-ABPC48 anti-idiotypic monoclonal antibodies

✍ Scribed by Pierre Legrain; Danielle Voegtle; Gérard Buttin; Pierre André Cazenave


Publisher
John Wiley and Sons
Year
1981
Tongue
English
Weight
936 KB
Volume
11
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Seventeen hybridomas, secreting monoclonal anti‐idiotypic antibodies (IDA) directed against the BALB/c ABPC48 idiotype, were isolated from one immunized BALB/c mouse. Several IDA also bind another BALB/c idiotype: UPC10. ABPC48 and UPC10 are both myeloma proteins with a β(2→6)‐polyfructosan (levan) specificity. The binding of every IDA to the ABPC48 idiotype can be completely inhibited by levan molecules, but at different concentrations. Mutual inhibition assays between the IDA made it possible to define six groups of IDA which bind at least three different idiotopes of ABPC48.

Sixteen IDA have been studied by means of mouse anti‐anti‐idiotypic antibodies (Ab3) directed against two of them, IDA3 and IDA10. Anti‐IDA3 Ab3 recognize idiotopes particular to IDA3 which are not found on other monoclonal anti‐idiotypic antibodies (Ab2). Anti‐IDA10 Ab3 cross‐reacts with several monoclonal Ab2, including Ab2 with different spectrotypes belonging or not to the same isotype and Ab2 with different specificities for the ABPC48 idiotype.

Some IDA10 idiotopes are present in the polyclonal anti‐ABPC48 antibody response of BALB/c, A/J and CBA mice showing that they are recurrent and that their expression is not linked to a particular Igh‐C haplotype. In contrast, IDA3 idiotopes are not detected in the same anti‐ABPC48 antisera.


📜 SIMILAR VOLUMES


Studies of the interactions between the
✍ Ann Erlandsson; Patrik Holm; Amanda Ullén; Torgny Stigbrand; Birgitta E. Sundstr 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 358 KB

## Abstract The monoclonal antibody TS1 against cytokeratin 8 and its antiidiotype αTS1 have been used for immunotargeting and therapy of carcinomas in experimental tumor model systems. The interaction surfaces between mab TS1, the cytokeratin 8 epitope, and its anti‐idiotypic antibody, αTS1, were